[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@LegendUSMA Legend Biotech Medical AffairsLegend Biotech Medical Affairs posts on X about events, ash, longterm, stanford university the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social topic influence events, ash, longterm, stanford university, thank you
Top accounts mentioned or mentioned by @surbhisidanamd @comycongress @yilinmdphd @plasmacellpete @bhemato @janakirammurali @leshune @amokhanmd @sandsjacob @tombmt133 @cohenadmmdoc @noopurrajemd @abhinavdeol @berdejajesus @lesokhinmd @dradrianarossi @szusmani @adamjschoenfeld @endmyeloma
Top posts by engagements in the last XX hours
"At the 2025 ASH Annual Meeting our focus remains clear: driving innovation that puts patients at the center. Excited to collaborate and share progress with the hematology community For more link here: #mmsm #lymsm"
X Link 2025-12-04T15:20Z XXX followers, XXX engagements
"Join Dr. Luciano Costa (@End_myeloma) for an oral presentation at #ASH25 to learn about the long-term progression-free survival benefit with a BCMA-directed #CART therapy in standard-risk relapsed / refractory multiple myeloma. For more link here: #mmsm"
X Link 2025-12-06T13:44Z XXX followers, 1015 engagements
"Dr. Binod Dhakal (@bhemato) presents at #ASH25 on effectiveness of bridging therapy corresponds to improved outcomes in the Phase X CARTITUDE-4 study of patients with relapsed lenalidomide-refractory multiple myeloma. For more link here: #mmsm #CART"
X Link 2025-12-06T18:20Z XXX followers, XXX engagements
"Robert Bowden (Johnson & Johnson) presents at #ASH25 on improved manufacturing outcomes with BCMA-directed #CART therapy in earlier lines of therapy. For more link here: #mmsm"
X Link 2025-12-06T19:01Z XXX followers, XXX engagements
"At #ASH25 Dr. Doris Hansen presents real-world incidence and management of non-ICANS neurological events following a BCMA-directed #CART cell therapy in multiple myeloma. Link: #mmsm"
X Link 2025-12-07T15:54Z XXX followers, XXX engagements
"Dr. Surbhi Sidana (@SurbhiSidanaMD) of Stanford University presents a quality-adjusted survival analysis of neurological events with a BCMA-directed #CART therapy vs standard of care in multiple myeloma patients in the CARTITUDE-4 trial. Link: #mmsm"
X Link 2025-12-08T13:25Z XXX followers, XXX engagements
"A heartfelt thank you to all who joined us at #ASH25 attended sessions and visited our posters. Together were pushing boundaries in #CART therapy and accelerating better outcomes for patients with #mmsm and #lymsm"
X Link 2025-12-09T21:03Z XXX followers, XX engagements